live
equin
infecti
anemia
viru
eiav
vaccin
strain
eiav
develop
vitro
attenu
virul
strain
eiav
demonstr
induc
protect
immun
laboratori
natur
eiav
infect
condit
detail
biolog
featur
attenu
viru
remain
investig
experiment
inocul
eiav
result
clinic
symptom
even
immunosuppress
treatment
previou
studi
investig
whether
replic
vaccin
strain
eiav
experiment
infect
hors
caus
histopatholog
lesion
develop
target
organ
lung
spleen
demonstr
support
eiav
replic
evalu
gross
macroscop
histolog
chang
found
eiav
caus
detect
histopatholog
lesion
replic
sever
hundr
time
slowli
parent
virul
strain
eiav
tissu
immunochem
assay
tissu
indic
primari
target
cell
eiav
monocytesmacrophag
eiav
also
infect
alveolar
epitheli
cell
vascular
endotheli
cell
addit
viral
strain
promot
upand
downregul
express
variou
cytokin
chemokin
implic
potenti
involv
cellular
factor
patholog
outcom
eiav
infect
host
immun
respons
taken
togeth
result
demonstr
eiav
vaccin
strain
caus
obviou
histopatholog
lesion
clinic
symptom
induc
uniqu
cytokin
respons
profil
featur
consid
essenti
eiav
function
effect
live
vaccin
equin
infecti
anemia
eia
caus
equin
infecti
anemia
viru
eiav
worldwid
diseas
equid
often
endem
cook
et
al
leroux
et
al
persist
infect
occur
hors
character
recur
cycl
viremia
clinic
symptom
includ
fever
anemia
ventral
edema
thrombocytopenia
gener
wast
leroux
et
al
eiavinfect
hors
typic
experi
classic
diseas
process
divid
three
stage
includ
acut
chronic
asymptomat
stage
cook
et
al
leroux
et
al
publish
studi
consist
confirm
acut
phase
persist
replic
site
eiav
macrophagerich
tissu
includ
spleen
bone
marrow
liver
kidney
lymph
node
peripher
blood
mononuclear
cell
pbmc
tissu
contain
fewer
virus
hors
infect
wildtyp
virul
strain
eiav
wyo
kono
et
al
sellon
et
al
primari
target
cell
eiav
replic
monocytemacrophag
lineag
macrovascular
endotheli
cell
also
infect
acut
stage
harrold
et
al
mauri
et
al
oak
et
al
howev
asymptomat
stage
although
spleen
liver
low
level
viral
replic
viru
usual
undetect
pbmc
tissu
hors
infect
weakli
virul
tissu
cultureadapt
strain
eiav
pv
harrold
et
al
addit
viral
mrna
found
tissu
macrophag
asymptomat
stage
therefor
differ
tissu
distribut
cellular
tropism
acut
asymptomat
phase
eiav
infect
live
attenu
vaccin
strain
eiav
develop
success
cultur
pathogen
strain
eiav
adapt
horsetrop
virul
strain
eiav
pathogen
hors
donkey
donkey
monocytederiv
macrophag
mdm
passag
eiav
extens
appli
china
vaccin
hors
mule
donkey
control
pandem
eia
shen
vaccin
strain
adapt
donkey
dermal
cell
fdd
improv
induct
immun
protect
facilit
manufactur
shen
et
al
wholeblood
transfer
hors
asymptomat
state
anim
shown
result
eiav
infect
diseas
recipi
hors
issel
et
al
treatment
hors
asymptomat
state
immunosuppress
drug
dexamethason
report
lead
recrudesc
diseas
kono
et
al
result
demonstr
longterm
unappar
asymptomat
state
revers
howev
approach
immunosuppress
induc
either
signific
boost
plasma
viral
load
activ
eia
hors
infect
attenu
eiav
vaccin
strain
et
al
shen
wang
result
suggest
live
eiav
vaccin
strain
uniqu
biolog
featur
tissu
cell
tropism
import
characterist
virus
affect
pathogenesi
therefor
interest
examin
whether
cellular
tropism
replic
vaccin
strain
tissu
differ
eiav
strain
abnorm
express
cytokin
chemokin
demonstr
infect
lentivirus
includ
human
immunodefici
felin
immunodefici
viru
fiv
simian
immunodefici
viru
siv
shown
contribut
system
tissu
damag
biancotto
et
al
qin
et
al
scott
et
al
express
level
report
increas
lymphoid
tissu
chronic
infect
result
lymphadenopathi
biancotto
et
al
studi
fivinfect
cat
demonstr
cytokin
dysregul
earlyand
lateterm
placenta
dramat
impact
pregnanc
outcom
viral
load
late
pregnanc
posit
correl
express
scott
et
al
addit
siv
infect
alter
chemokin
network
local
immun
environ
lung
critic
outcom
viral
infect
qin
et
al
pulmonari
symptom
associ
siv
infect
close
associ
increas
express
lung
rhesu
macaqu
qin
et
al
eiav
infect
also
result
interstiti
pulmonari
patholog
similar
observ
hivinfect
children
doffman
miller
sivinfect
macaqu
qin
et
al
fivinfect
cat
bolfa
et
al
cador
et
al
vitro
infect
primari
monocytesmacrophag
also
induc
differenti
express
sever
cytokin
eg
chemokin
eg
eiav
virul
strain
eiav
vaccin
strain
eiav
lin
et
al
howev
littl
known
cytokin
respons
tissu
eiav
eiav
infect
hors
compar
virolog
immunolog
studi
chines
pathogen
strain
partial
complet
attenu
strain
extens
perform
laboratori
year
lin
et
al
liu
et
al
et
al
wang
et
al
better
understand
differ
tissu
tropism
pathogenesi
chines
pathogen
strain
complet
attenu
strain
six
hors
three
group
inocul
either
pathogen
eiav
strain
complet
attenu
eiav
vaccin
strain
addit
three
hors
place
neg
control
group
patholog
damag
replic
statu
cellular
tropism
well
host
respons
lung
spleen
infect
anim
examin
nine
twoyearold
male
hors
use
studi
hors
neg
equin
arter
viru
eav
equin
influenza
viru
eiv
equin
herp
viru
ehv
initi
studi
eiav
infect
screen
three
month
prior
experi
use
agar
gel
immunodiffus
test
agid
vmrd
usa
three
time
interv
one
month
anim
experi
carri
approv
anim
handl
protocol
accord
guidelin
anim
manag
committe
chines
harbin
veterinari
research
institut
eiav
strain
use
studi
store
harbin
veterinari
research
institut
hors
randomli
separ
three
group
three
hors
group
subcutan
inocul
tcid
tissu
cultur
infect
dose
vaccin
strain
eiav
hors
inocul
dose
eiav
develop
protect
immun
challeng
eiav
shen
wang
shen
group
b
contain
three
hors
inocul
titer
pathogen
strain
eiav
follow
previous
describ
protocol
shen
wang
shen
last
three
hors
group
c
includ
inject
volum
salin
neg
control
hors
group
separ
fed
breed
condit
control
ensur
anim
welfar
bodi
temperatur
platelet
count
clinic
symptom
hors
inocul
eiav
monitor
day
blood
sampl
obtain
tissu
collect
histopatholog
virolog
cytokin
assay
day
euthan
pbmc
separ
blood
previous
describ
lin
et
al
three
differ
region
lung
spleen
sampl
tissu
sampl
obtain
duplic
one
fix
neutral
phosphatebuff
pb
formalin
histopatholog
assay
store
separ
c
viral
load
cytokin
analys
fixat
h
tissu
process
routin
histolog
tissu
block
slice
section
stain
standard
hematoxylin
eosin
h
e
immunohistochem
stain
perform
detect
viral
antigen
tissu
accord
publish
protocol
bolfa
et
al
present
studi
monoclon
antibodi
prepar
laboratori
use
primari
antibodi
goat
antimous
igg
label
horseradish
peroxidas
use
secondari
antibodi
beyotim
china
dab
diaminobenzidin
beyotim
china
use
chromogen
hematoxylin
beyotim
china
use
counterstain
control
specif
includ
uninfect
infect
tissu
section
incub
primari
antibodi
tissu
section
examin
light
microscopi
leica
germani
tissu
homogen
prepar
grind
tissu
sampl
liquid
nitrogen
mortar
total
rna
extract
tissu
sampl
use
trizol
regent
invitrogen
usa
accord
manufactur
instruct
total
rna
treat
remov
genom
dna
use
primescript
rt
reagent
kit
gdna
eras
perfect
real
time
kit
takara
japan
prior
undergo
revers
transcript
briefli
remov
genom
dna
reaction
mixtur
contain
l
total
rna
g
l
gdna
buffer
l
gdna
eras
l
depctreat
water
prepar
reaction
condit
follow
c
min
follow
storag
c
revers
transcript
perform
total
volum
l
l
reversetranscript
mix
ad
reaction
solut
step
includ
l
primescript
buffer
realtim
pcr
l
primescript
rt
enzym
mix
l
rt
primer
mix
l
rnasefre
dh
reaction
condit
follow
c
min
c
storag
c
three
independ
rna
extract
perform
tissu
site
result
cdna
use
correspond
templat
viral
transcript
amplif
tissu
viral
load
cytokin
analys
sampl
store
c
use
viral
transcript
amplifi
perform
revers
transcript
cdna
templat
nest
pcr
primer
use
includ
outer
inner
primer
anneal
temperatur
primer
set
indic
supplementari
tabl
pcr
perform
l
reaction
volum
use
takara
la
pcr
amplif
kit
version
takara
japan
follow
manufactur
instruct
steril
distil
water
cdna
templat
prepar
healthi
tissu
use
blank
neg
control
respect
pcr
product
analyz
agaros
gel
electrophoresi
eiav
rna
lung
spleen
measur
use
quantit
realtim
pcr
qrtpcr
present
viral
copi
number
per
g
total
tissu
rna
standard
prepar
previous
describ
wei
et
al
reaction
perform
optic
plate
roch
switzerland
l
volum
includ
l
cdna
templat
l
sybr
premix
ex
taq
ii
tli
rnaseh
plu
takara
japan
l
pcr
forward
primer
l
pcr
revers
primer
l
rnasefre
water
reaction
condit
follow
c
cycl
c
anneal
temperatur
use
gene
indic
supplementari
tabl
final
extens
step
c
sampl
test
quadrupl
data
collect
analyz
qpcr
system
stratagen
usa
express
level
lung
spleen
determin
rtpcr
briefli
rna
extract
describ
sampl
assess
quadrupl
use
refer
mrna
target
mrna
sampl
run
parallel
plate
reaction
condit
describ
qrtpcr
eiav
genom
rna
rel
cytokin
express
level
calcul
normal
c
valu
determin
differenti
express
target
gene
hors
infect
either
eiav
eiav
fold
chang
cytokin
express
level
tissu
eiavinfect
hors
compar
uninfect
hors
serv
calibr
calcul
use
ct
method
abel
et
al
statist
analys
realtim
rtpcr
data
includ
viral
load
cytokin
mrna
level
pbmc
tissu
eiavinfect
hors
perform
compar
experiment
group
use
twotail
student
test
result
consid
statist
signific
signific
p
valu
less
respect
spearman
correl
coeffici
r
determin
viral
load
fold
chang
specif
cytokin
sampl
obtain
tissu
site
analys
perform
use
spss
softwar
ibm
usa
analyt
graph
construct
use
graphpad
prism
graphpad
softwar
usa
examin
pathogen
vaccin
strain
eiav
hors
experiment
infect
three
hors
group
tcid
strain
anoth
two
group
hors
group
b
group
c
three
hors
inocul
either
volum
pathogen
strain
eiav
salin
posit
neg
control
respect
three
hors
infect
eiav
develop
activ
eia
bodi
temperatur
c
platelet
count
plasma
viral
load
ml
within
month
postinfect
euthan
day
postinfect
detect
eiaassoci
symptom
observ
hors
two
group
group
c
supplementari
tabl
clear
alveolar
outlin
normal
bronchial
structur
lung
fig
e
normal
profil
white
pulp
moder
cell
densiti
red
pulp
spleen
observ
hors
group
c
fig
f
contrast
alveolar
wall
thicken
arrowhead
sever
histolog
inflamm
emerg
macrophag
cell
degener
necrosi
alveolar
wall
arrow
identifi
lung
hors
infect
eiav
fig
furthermor
seriou
hyperemia
observ
red
pulp
arrowhead
necrot
zone
varabl
size
appear
white
pulp
within
either
structur
blur
cytoplasm
ruptur
nuclei
due
chromatin
dissolut
lymphocyt
observ
spleen
eiav
infect
hors
arrow
fig
capsid
protein
contain
antigen
epitop
cellmedi
immun
respons
abund
protein
eiav
alvarez
et
al
hu
et
al
immunohistolog
reveal
addit
detect
alveolar
wall
lung
fig
c
white
pulp
spleen
fig
eiav
eiav
infect
hors
viral
protein
found
vessel
tissu
eiav
infect
hors
fig
accord
cell
morpholog
locat
antigen
mainli
distribut
alveolar
epitheli
cell
vascular
endotheli
cell
lung
fig
vascular
endotheli
cell
spleen
hors
infect
eiav
fig
well
macrophag
alveolar
wall
lung
fig
c
macrophag
spleen
fig
eiav
infect
eiav
infect
hors
signal
detect
lung
spleen
neg
control
group
c
fig
f
level
viral
load
host
consid
threshold
type
host
respons
character
threshold
viru
detect
seroconvers
vaccin
diseas
whitney
ruprecht
hors
infect
eiav
exhibit
typic
clinic
symptom
circul
viral
load
reach
copiesml
higher
cook
et
al
therefor
detect
eiav
rna
copi
number
indic
tissu
evalu
correl
patholog
chang
tissu
compar
cellassoci
viral
rna
level
tissu
eiav
infect
eiav
infect
hors
viral
rna
quantifi
qrtpcr
viral
rna
detect
lung
spleen
three
eiav
inocul
hors
group
mean
level
viral
copiesg
total
rna
respect
fig
mean
viral
rna
level
pbmc
significantli
higher
viral
copiesg
total
rna
fig
signific
differ
observ
viral
load
pbmc
lung
group
p
howev
eiav
infect
hors
group
b
mean
viral
rna
level
copiesg
total
rna
lung
spleen
respect
higher
level
viral
copiesg
total
rna
observ
pbmc
fig
furthermor
signific
differ
viral
load
among
tissu
group
b
howev
viral
rna
level
lung
spleen
pbmc
eiav
infect
hors
significantli
higher
eiav
infect
hors
p
three
confirm
viru
replic
lung
spleen
eiav
inocul
hors
nest
pcr
perform
amplifi
viral
transcript
includ
gag
pol
env
three
transcript
clearli
detect
lung
spleen
tissu
eiavinfect
hors
fig
b
result
indic
viral
rna
vaccin
virul
strain
like
present
fulllength
form
tissu
suggest
synthesi
viral
genom
none
neg
control
anim
test
posit
viral
rna
eiav
promot
upand
downregul
express
differ
cytokin
chemokin
critic
involv
host
respons
includ
immun
pathogenesi
previou
studi
reveal
express
level
cytokin
chemokin
differ
cultiv
mdm
presenc
pathogen
versu
attenu
eiav
strain
lin
et
al
three
sampl
lung
spleen
measur
p
p
compar
correspond
sampl
group
p
p
compar
differ
sampl
within
group
triangl
squar
circl
repres
differ
anim
respect
result
pbmc
hors
express
mean
valu
tissu
site
express
mean
sd
n
investig
whether
eiav
vaccin
strain
eiav
also
induc
differ
cytokin
respons
induc
pathogen
strain
eiav
vivo
rel
mrna
express
level
eight
cytokin
four
chemokin
examin
lung
spleen
hors
inocul
virus
level
compar
uninfect
control
group
accord
amplif
curv
pcr
effici
demonstr
similar
amplif
effici
among
target
cytokin
refer
mrna
eiav
eiav
infect
lung
spleen
mean
fold
chang
mrna
level
increas
twofold
rel
uninfect
group
fold
chang
eiav
inocul
hors
much
lower
eiav
infect
hors
especi
differ
close
twofold
addit
express
level
eiav
infect
lung
spleen
eiav
infect
spleen
enhanc
follow
eiav
infect
tabl
eiav
makedli
induc
express
cytokin
differ
induc
eiav
mrna
level
decreas
respect
eiav
infect
lung
upregul
eiav
notabl
vaccin
strain
enhanc
mrna
express
mean
spleen
wherea
pathogen
eiav
strain
almost
effect
mrna
express
similarli
express
lung
significantli
higher
eiav
infect
group
differ
mean
fold
chang
tabl
host
immun
inflamm
consid
associ
prolifer
statu
infect
viru
next
examin
possibl
correl
level
eiav
replic
cytokin
express
correspond
site
tissu
infect
either
eiav
eiav
eiav
inocul
hors
viral
rna
copi
number
posit
correl
mrna
express
level
r
p
r
p
fig
tabl
eiav
infect
group
posit
correl
viral
rna
copi
number
r
p
two
cytokin
r
p
r
p
neg
correl
tabl
addit
chemokin
mediat
cell
migrat
recruit
leukocyt
process
secret
cytokin
chemokin
regul
distinct
intracellular
signal
event
baggiolini
rollin
thu
examin
possibl
correl
among
express
cytokineschemokin
correspond
site
eiav
inocul
hors
express
posit
correl
r
p
r
p
express
posit
correl
r
p
r
p
respect
addit
express
posit
correl
r
p
r
p
eiav
inocul
hors
express
posit
correl
r
p
express
posit
correl
r
p
addit
express
posit
correl
r
p
neg
correl
r
p
tabl
studi
observ
excess
respons
sever
cytokin
associ
high
level
prolifer
pathogen
strain
eiav
multipl
sever
organ
lesion
cellular
factor
mainli
proinflammatori
cytokin
antivir
factor
chemokin
primarili
includ
also
call
proinflammatori
cytokin
attract
activ
immunocyt
includ
cell
b
cell
phagocyt
baggiolini
clarklewi
wong
et
al
although
import
role
induc
regul
immun
protect
invad
microb
two
cytokin
particularli
larg
involv
develop
lesion
caus
overact
immun
respons
observ
infect
influenza
viru
et
al
de
jong
et
al
siv
sever
acut
respiratori
syndrom
sar
coronaviru
imai
et
al
mukura
et
al
robert
et
al
type
interferon
trigger
potent
innat
immun
respons
host
defens
system
isaac
lindenmann
play
import
role
antivir
antibact
c
c
ns
ns
ns
ns
ns
ns
ui
uninfect
ns
signific
arithmet
mean
fold
chang
express
level
target
gene
rel
uninfect
anim
data
mean
sem
b
increas
express
level
cytokin
chemokin
fold
chang
c
unchang
express
level
defin
fold
chang
underlin
data
decreas
express
level
fold
chang
student
ttest
use
comparison
fig
exampl
correl
analys
cytokin
mrna
express
level
viral
rna
copi
number
tissu
hors
eiav
genom
rna
b
mrna
quantifi
rtpcr
describ
fig
spearman
correl
coeffici
statist
signific
r
p
valu
signific
p
signific
p
provid
graph
rial
anticanc
respons
activ
immatur
dendrit
cell
upregul
express
chemokin
chemokin
receptor
found
regul
adapt
immun
promot
gener
neutral
antibodi
enhanc
celldepend
antibodi
respons
knockout
function
type
ifn
receptor
mous
model
shown
deactiv
associ
signal
pathway
trinchieri
dramat
increas
sever
symptom
virusinfect
mammalian
host
muller
et
al
contrast
vaccin
strain
eiav
significantli
lower
replic
level
induc
moder
elev
express
cytokin
test
parallel
compar
pathogen
strain
eiav
except
spleen
lung
therefor
present
result
indic
differ
eiav
pathogen
larg
determin
differ
viral
replic
host
respons
multipl
organ
spleen
lung
also
term
protein
produc
respons
monocyt
endotheli
cell
fibroblast
attract
differ
type
immunocyt
nevil
et
al
express
report
increas
encephalit
brain
lung
affect
directli
indirectli
infect
simianhuman
immunodefici
viru
shiv
siv
sassevil
et
al
also
shown
associ
develop
pneumonia
recruit
addit
inflammatori
cell
lung
viral
infect
schaefer
et
al
sui
et
al
interstiti
pneumonia
report
eiavinfect
hors
similar
sivinfect
macaqu
human
bolfa
et
al
upregul
express
coupl
patholog
damag
implic
involv
chemokin
develop
pneumonia
associ
eiav
infect
also
known
stromal
cellderiv
factor
antiapoptot
chemokin
chemokin
involv
enhanc
cell
surviv
inactiv
member
apoptot
pathway
posttransl
level
bana
et
al
guo
et
al
qiup
et
al
downregul
mrna
express
chemokin
lung
lymphoid
tissu
siv
infect
report
contribut
increas
apoptosi
host
cell
qin
et
al
qin
et
al
upregul
mrna
express
respect
eiav
infect
spleen
increas
mrna
express
eiav
infect
lung
observ
studi
suggest
host
respons
trigger
eiav
infect
reduc
cellular
apoptosi
present
studi
reveal
pathogen
vaccin
strain
replic
host
tissu
howev
caus
differ
clinic
histopatholog
outcom
report
viral
tropism
refer
specif
certain
viru
particular
cell
cellular
tropism
tissu
type
tissu
tropism
import
factor
determin
outcom
viral
infect
mcfadden
et
al
consist
report
harrold
et
al
mauri
et
al
oak
et
al
oak
et
al
data
demonstr
macrophag
primari
target
cell
eiav
infect
replic
eiav
hors
alveolar
epitheli
cell
vascular
endotheli
cell
lung
vascular
endotheli
cell
spleen
also
eiav
posit
eiav
infect
hors
previou
studi
observ
multipl
consensu
mutat
macrophageand
fibroblastadapt
eiav
strain
process
vitro
attenu
especi
ltr
payn
et
al
env
region
ltr
region
contain
transcript
initi
site
thu
larg
determin
cellular
tropism
payn
et
al
discontinu
area
cterminu
eiav
glycoprotein
identifi
bind
domain
eiav
receptor
zhang
et
al
thu
reason
specul
cellular
tropism
affect
sequenc
variabl
among
strain
notabl
contrast
investig
cytokin
chemokin
strongli
upregul
eiav
mrna
express
import
regul
immun
respons
effect
stimul
approxim
increas
spleen
eiav
fluctuat
around
baselin
uninfect
control
group
spleen
infect
eiav
result
consist
studi
show
product
serum
togeth
markedli
increas
maintain
high
concentr
approxim
dpi
hors
inocul
vaccin
strain
eiav
exhibit
low
level
upregul
hors
infect
eiav
zhang
et
al
well
accept
express
import
index
cellmedi
immun
especi
cytotox
lymphocyt
ctl
respons
lentivir
infect
includ
siv
correl
vaccineinduc
immun
martin
et
al
roff
et
al
furthermor
stimul
function
polar
monocytederiv
macrophag
classic
cell
express
high
level
proinflammatori
cytokin
provid
protect
viral
microbi
infect
mantovani
et
al
mantovani
et
al
addit
power
induc
program
strongli
attenu
immun
reaction
fli
et
al
keir
et
al
specul
enhanc
express
eiav
vaccin
strain
involv
protect
immun
respons
pathogen
strain
remark
decreas
number
inflammatoryrel
tissu
lesion
caus
eiav
infect
correl
analysi
eiav
vrna
copi
number
cytokin
express
level
reveal
vrna
copi
number
attenu
eiav
posit
correl
pathogen
eiav
prolifer
level
posit
correl
neg
correl
data
indic
although
sever
hundredfold
higher
prolifer
level
eiav
larg
determin
significantli
higher
express
level
panel
cytokineschemokin
shown
tabl
differ
sequenc
doublestrand
ds
rna
vaccin
pathogen
viral
genom
may
differ
effect
induc
express
cytokin
play
import
role
immun
respons
addit
type
viral
protein
featur
viral
genom
materi
also
greatli
influenc
intracellular
signal
network
previous
demonstr
compar
similar
prolifer
level
pathogen
strain
eiav
vaccin
strain
induc
activ
tolllik
receptor
approxim
intracellular
pattern
recognit
receptor
ppr
specif
activ
dsrna
et
al
assum
vaccin
vrna
copi
numberdepend
induct
express
antivir
antiinflammatori
partli
respons
attenu
virul
eiav
addit
neg
correl
eiav
vrna
copi
number
express
suggest
eiav
pathogen
strain
inhibitori
effect
potent
antivir
protein
effect
demonstr
eiav
inocul
hors
markedli
increas
upregul
express
lung
compar
spleen
major
peripher
immun
organ
harbor
much
macrophag
princip
target
cell
eiav
tenfold
greater
number
eiav
virion
summari
visibl
patholog
lesion
result
infect
observ
hors
experiment
infect
attenu
vaccin
strain
eiav
contrast
infect
parent
pathogen
strain
eiav
caus
sever
hyperemia
hemorrhag
necrosi
multipl
organ
infect
anim
follow
biolog
characterist
attenu
viru
may
caus
differ
patholog
rel
low
copi
number
stabl
replic
statu
tissu
ii
differ
cellular
tropism
iii
differ
induct
cytokin
chemokin
express
level
spectra
attenu
virul
appropri
induct
cytokin
respons
eiav
vaccin
strain
may
provid
host
suffici
time
immun
matur
develop
protect
immun
elicit
correct
antigen
stimul
vaccin
author
report
conflict
interest
prepar
manuscript
